Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-178,883
Closed -$80K 3760
2025
Q2
$80K Buy
+178,883
New +$77.8K ﹤0.01% 2243
2025
Q1
Sell
-91,270
Closed -$60K 3472
2024
Q4
$60K Buy
+91,270
New +$63.4K ﹤0.01% 2090
2024
Q2
Sell
-529,578
Closed -$688K 3194
2024
Q1
$688K Buy
529,578
+519,569
+5,191% +$544K ﹤0.01% 1080
2023
Q4
$5K Buy
+10,009
New +$6.92K ﹤0.01% 2134
2023
Q3
Sell
-120,834
Closed -$88K 3177
2023
Q2
$88K Buy
+120,834
New +$112K ﹤0.01% 1988
2023
Q1
Sell
-544,239
Closed -$522K 3265
2022
Q4
$522K Buy
+544,239
New +$769K 0.01% 1375
2022
Q3
Sell
-85,545
Closed -$299K 3567
2022
Q2
$299K Buy
+85,545
New +$320K ﹤0.01% 2024

Other funds holding VXRT

HRT Financial's VXRT Position: Q3 2025 in Review

HRT Financial sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 178,883 shares — an estimated $80K sold.

HRT Financial first reported a position in VXRT in Q2 2022 and held it in 7 quarters. The position peaked at $688K in Q1 2024. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • HRT Financial reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 178,883 Vaxart shares in Q3 2025, an estimated $80K.
  • HRT Financial first reported a position in Vaxart in Q2 2022 and held it in 7 quarters.
  • HRT Financial's Vaxart position peaked at $688K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.